Professor | Dalian Dermatosis Hospital | China
Dr. Chengzhi Lv, Director of Dalian Dermatosis Hospital, is a distinguished researcher and clinician specializing in inflammatory skin diseases. He has developed a cross-disciplinary research framework to uncover the molecular mechanisms linking skin barrier homeostasis and systemic inflammatory factors, including IL-1β, IL-6, and TNF-α. Dr. Lv holds a robust academic background with numerous completed and ongoing research projects funded by prestigious institutions such as the National Natural Science Foundation of China, the Chinese Academy of Medical Sciences, and the Guangdong Provincial Department of Science and Technology. His work spans advanced studies on psoriasis, vitiligo, melanoma, and autoimmune diseases, as well as the development of emollients and novel therapeutic approaches integrating traditional Chinese and Western medicine. He has authored several books, including Chinese and Western Medicine Dermatology and Venereology and Psoriasis Diagnosis and Treatment Manual, and published widely in high-impact journals such as Frontiers in Immunology and the Journal of the European Academy of Dermatology and Venereology. His contributions include pioneering the “Dalian Model” for comprehensive psoriasis management, which significantly reduces recurrence rates. Dr. Lv is also a patent holder for innovative dermatological treatments and serves as Editor-in-Chief of both the Chinese Journal of Integrated Traditional Chinese and Western Medicine in Dermatology and Venereology and the Journal of Practical Dermatology. Recognized nationally for his leadership in clinical dermatology, Dr. Lv continues to advance the integration of clinical care, research, and innovation to improve outcomes for patients with chronic skin disorders. He has 521 citations from 464 documents with an h-index of 12.
Publications
1. Panpan Liu; Yehong Kuang; Li Ye; Cong Peng; Wangqing Chen; Minxue Shen; Mi Zhang; Wu Zhu;Chengzhi Lv; Xiang Chen ; Predicting the risk of psoriatic arthritis in plaque psoriasis patients: development and assessment of a new predictive nomogram, Frontiers in Immunology, 2022, 12；
2. L Ye; Z Wang; Y Kim; PM Elias; T Li; S Wen; J Song; C Lv; B Yang; MQ Man ; A Topical Emollient Mitigates the Progression of Cognitive Impairment in the Elderly: A Randomized, Open‐ Label Pilot Trial, Journal of the European Academy of Dermatology and Venereology, 2022, 36(8): 1382-1388；
3. Yehong Kuang; Yi Xiao; Zhiqin Fang; Yichi Zhang; Minxue Shen; Xiang Chen; Mingliang Chen; Chengzhi Lv; Wu Zhu ; Association of serum vitamin D with psoriasis and effect modification by central obesity., Front Med (Lausanne), 2020, 7(236)；
4. Ye, L.; Mauro, T. M.; Dang, E.; Wang, G.; Hu, L. Z.; Yu, C.; Jeong, S.; Feingold, K.; Elias, P. M.; Lv, C. Z.; Man, M. Q. ; Topical applications of an emollient reduce circulating pro-inflammatory cytokine levels in chronically aged humans: a pilot clinical study, Journal of the European Academy of Dermatology and Venereology, 2019, 33(11): 2197-2201；
5. Ye, L; Wang, Z; Li, Z; Lv, C; Man, M Q ; Validation of GPSkin Barrier((R)) for assessing epidermal permeability barrier function and stratum corneum hydration in humans, Skin Research and Technology, 2018, 25(1): 25-29